RT Journal Article
SR Electronic
T1 Dosimetry for Radiopharmaceutical Therapy: The European Perspective
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 73S
OP 79S
DO 10.2967/jnumed.121.262754
VO 62
IS Supplement 3
A1 Michael Lassmann
A1 Uta Eberlein
A1 Jonathan Gear
A1 Mark Konijnenberg
A1 Jolanta Kunikowska
YR 2021
UL http://jnm.snmjournals.org/content/62/Supplement_3/73S.abstract
AB This review presents efforts in Europe over the last few years with respect to standardization of quantitative imaging and dosimetry and comprises the results of several European research projects on practices regarding radiopharmaceutical therapies (RPTs). Because the European Union has regulatory requirements concerning dosimetry in RPTs, the European Association of Nuclear Medicine released a position paper in 2021 on the use of dosimetry under these requirements. The importance of radiobiology for RPTs is elucidated in another position paper by the European Association of Nuclear Medicine. Furthermore, how dosimetry interacts with clinical requirements is described, with several clinical examples. In the future, more efforts need to be undertaken to increase teaching and standardization efforts and to incorporate radiobiology for further individualizing patient treatment, with the aim of improving the outcome and safety of RPTs.